AC

Abhishek Chander

Active Director Designated Partner DIN 10509112
DIN 10509112 First appointment Feb 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Abhishek Chander

Data last updated:

Abhishek Chander is a Designated Partner at Requiron Medtech Llp (since 2024). The company operates in Healthcare. Requiron Medtech Llp reported revenue of ₹4.9 Lakh (FY 2022).

DIN 10509112
Primary Designation Designated Partner
Industry Healthcare
First Appointment 19 Feb 2024
Oldest Company Age 8 yrs
Largest company Requiron Medtech Llp · ₹4.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Feb 20242018₹4.9 Lakh (FY 2022)Active

Board colleagues of Abhishek Chander

NameDINCompanyDesignation
Pratul Nayar10501592Requiron Medtech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Requiron Medtech Llp
Premium access

Shareholding and investment profile for Abhishek Chander

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Chander

Abhishek Chander currently holds 1 directorship: Requiron Medtech Llp (Designated Partner, since 19 Feb 2024, revenue ₹4.9 Lakh (FY 2022)).

Abhishek Chander was first appointed on 19 Feb 2024 as Designated Partner at Requiron Medtech Llp.

The current boards of Abhishek Chander's companies include Pratul Nayar (Requiron Medtech Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available